Polymorphisms in E-cadherin (CDH1) result in a mislocalised cytoplasmic protein that is associated with Crohn's disease

Gut

Volumn 58, Issue 8, 2009, Pages 1121-1127

  Muise, A M ^a   Walters, T D ^a   Glowacka, W K ^a   Griffiths, A M ^a   Ngan, B Y ^a   Lan, H ^b   Xu, W ^b   Silverberg, M S ^b   Rotin, D ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; UVOMORULIN;

ADOLESCENT; ALLELE; ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL STRAIN; CELL STRAIN CACO 2; CHILD; CROHN DISEASE; CYTOPLASM; EPITHELIUM CELL; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HAPLOTYPE MAP; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; INTESTINE EPITHELIUM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; CADHERINS; CELL LINE; CHILD; CROHN DISEASE; CYTOPLASM; EPITHELIAL CELLS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTESTINAL MUCOSA; LINKAGE DISEQUILIBRIUM; MALE; MICROSCOPY, CONFOCAL; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 67650230022     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.175117     Document Type: Article

References (56)

1. Ivanov AI, Nusrat A, Parkos CA. The epithelium in inflammatory bowel disease: potential role of endocytosis of junctional proteins in barrier disruption. Novartis Found Symp 2004;263:115-24; discussion 24-32, 211-8.
2. Hermiston ML, Gordon JI. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 1995;270:1203-7.
3. Bruewer M, Samarin S, Nusrat A. Inflammatory bowel disease and the apical junctional complex. Ann N Y Acad Sci 2006;1072:242-52.
4. Muise AM, Walters T, Wine E, et al. Protein-tyrosine phosphatase sigma is associated with ulcerative colitis. Curr Biol 2007;17:1212-8.
5. McGovern DP, Taylor KD, Landers C, et al. MAGI2 genetic variation and inflammatory bowel disease. Inflamm Bowel Dis 2009;15:75-83.
6. Wapenaar MC, Monsuur AJ, van Bodegraven AA, et al. Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis. Gut 2008;57:463-7.
7. Hermiston ML, Gordon JI. In vivo analysis of cadherin function in the mouse intestinal epithelium: essential roles in adhesion, maintenance of differentiation, and regulation of programmed cell death. J Cell Biol 1995;129:489-506.
8. Jankowski JA, Bedford FK, Boulton RA, et al. Alterations in classical cadherins associated with progression in ulcerative and Crohn's colitis. Lab Invest 1998;78:1155-67.
9. Gassler N, Rohr C, Schneider A, et al. Inflammatory bowel disease is associated with changes of enterocytic junctions. Am J Physiol Gastrointest Liver Physiol 2001;281:G216-28.
10. Karayiannakis AJ, Syrigos KN, Efstathiou J, et al. Expression of catenins and Ecadherin during epithelial restitution in inflammatory bowel disease. J Pathol 1998;185:413-8.
11. Demetter P, De Vos M, Van Damme N, et al. Focal up-regulation of E-cadherin-catenin complex in inflamed bowel mucosa but reduced expression in ulcer-associated cell lineage. Am J Clin Pathol 2000;114:364-70.
12. Wu S, Rhee KJ, Zhang M, et al. Bacteroides fragilis toxin stimulates intestinal epithelial cell shedding and gamma-secretase-dependent E-cadherin cleavage. J Cell Sci 2007;120:1944-52.
13. Frank CF, Hostetter MK. Cleavage of E-cadherin: a mechanism for disruption of the intestinal epithelial barrier by Candida albicans. Transl Res 2007;149:211-22.
14. Sasaki M, Sitaraman SV, Babbin BA, et al. Invasive Escherichia coli are a feature of Crohn's disease. Lab Invest 2007;87:1042-54.
15. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
16. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
17. Hampe J, Frenzel H, Mirza MM, et al. Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p. Proc Natl Acad Sci U S A 2002;99:321-6.
18. Shugart YY, Silverberg MS, Duerr RH, et al. An SNP linkage scan identifies significant Crohn's disease loci on chromosomes 13q13.3 and, in Jewish families, on 1p35.2 and 3q29. Genes Immun 2008;9:161-7.
19. de Jong DJ, Franke B, Naber AH, et al. No evidence for involvement of IL-4R and CD11B from the IBD1 region and STAT6 in the IBD2 region in Crohn's disease. Eur J Hum Genet 2003;11:884-7.
20. Silverberg MS, Daly MJ, Moskovitz DN, et al. Diagnostic misclassification reduces the ability to detect linkage in inflammatory bowel disease genetic studies. Gut 2001;49:773-6.
21. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19(Suppl A):5-36.
22. International HapMap Consortium. The International HapMap Project. Nature 2003;426:789-96.
23. de Bakker PI, Yelensky R, Pe'er I, et al. Efficiency and power in genetic association studies. Nat Genet 2005;37:1217-23.
24. Lake SL, Blacker D, Laird NM. Family-based tests of association in the presence of linkage. Am J Hum Genet 2000;67:1515-25.
25. Horvath S, Xu X, Laird NM. The family based association test method: strategies for studying general genotype-phenotype associations. Eur J Hum Genet 2001;9:301-6.
26. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5.
27. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-78.
28. Pak Y, Glowacka WK, Bruce MC, et al. Transport of LAPTM5 to lysosomes requires association with the ubiquitin ligase Nedd4, but not LAPTM5 ubiquitination. J Cell Biol 2006;175:631-45.
29. ShoreEM, NelsonWJ. Biosynthesis of the cell adhesion molecule uvomorulin (E-cadherin) in Madin-Darby canine kidney epithelial cells. J Biol Chem 1991;266:19672-80.
30. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006;314:1461-3.
31. Rioux JD, Xavier RJ, Taylor KD, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007;39:596-604.
32. Libioulle C, Louis E, Hansoul S, et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet 2007;3:e58.
33. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008;40:955-62.
34. Altshuler D, Daly M. Guilt beyond a reasonable doubt. Nat Genet 2007;39:813-5.
35. Kaser A, Lee AH, Franke A, et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 2008;134:743-56.
36. Brooks-Wilson AR, Kaurah P, Suriano G, et al. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet 2004;41:508-17.
37. Stemmler MP, Hecht A, Kemler R. E-cadherin intron 2 contains cis-regulatory elements essential for gene expression. Development 2005;132:965-76.
38. Kochetov AV. AUG codons at the beginning of protein coding sequences are frequent in eukaryotic mRNAs with a suboptimal start codon context. Bioinformatics 2005;21:837-40.
39. Kochetov AV, Sarai A, Rogozin IB, et al. The role of alternative translation start sites in the generation of human protein diversity. Mol Genet Genomics 2005;273:491-6.
40. Riethmacher D, Brinkmann V, Birchmeier C. A targeted mutation in the mouse Ecadherin gene results in defective preimplantation development. Proc Natl Acad Sci U S A 1995;92:855-9.
41. van Es JH, van Gijn ME, Riccio O, et al. Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 2005;435:959-63.
42. Heazlewood CK, Cook MC, Eri R, et al. Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med 2008;5:e54.
43. Hollander D. Crohn's disease - a permeability disorder of the tight junction? Gut 1988;29:1621-4.
44. Weber CR, Turner JR. Inflammatory bowel disease: is it really just another break in the wall? Gut 2007;56:6-8.
45. Arrieta MC, Bistritz L, Meddings JB. Alterations in intestinal permeability. Gut 2006;55:1512-20.
46. Arnott ID, Kingstone K, Ghosh S. Abnormal intestinal permeability predicts relapse in inactive Crohn disease. Scand J Gastroenterol 2000;35:1163-9.
47. Wyatt J, Oberhuber G, Pongratz S, et al. Increased gastric and intestinal permeability in patients with Crohn's disease. Am J Gastroenterol 1997;92:1891-6.
48. Wyatt J, Vogelsang H, Hubl W, et al. Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 1993;341:1437-9.
49. Mankertz J, Schulzke JD. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications. Curr Opin Gastroenterol 2007;23:379-83.
50. Irvine EJ, Marshall JK. Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. Gastroenterology 2000;119:1740-4.
51. Wolters VM, Verbeek WH, Zhernakova A, et al. The MYO9B gene is a strong risk factor for developing refractory celiac disease. Clin Gastroenterol Hepatol 2007;5:1399-405, 405 e1-2.
52. Muise A, Rotin D. Apical junction complex proteins and ulcerative colitis: a focus on the PTPRS gene. Expert Rev Mol Diagn 2008;8:465-77.
53. Kawajiri A, Itoh N, Fukata M, et al. Identification of a novel beta-catenin-interacting protein. Biochem Biophys Res Commun 2000;273:712-7.
54. Subauste MC, Nalbant P, Adamson ED, et al. Vinculin controls PTEN protein level by maintaining the interaction of the adherens junction protein beta-catenin with the scaffolding protein MAGI-2. J Biol Chem 2005;280:5676-81.
55. Stoll M, Corneliussen B, Costello CM, et al. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 2004;36:476-80.
56. Nechiporuk T, Fernandez TE, Vasioukhin V. Failure of epithelial tube maintenance causes hydrocephalus and renal cysts in Dlg5-/- mice. Dev Cell 2007;13:338-50.